D.E. Shaw & Co
IMGN

D.E. Shaw & Co’s Immunogen Inc IMGN Stock Holding History

D.E. Shaw & Co’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,700
Closed -$175K – 4602
2014
Q1 		$175K Hold
11,700
– – ﹤0.01% 4103
2013
Q4 		$172K Buy
+11,700
New +$180K ﹤0.01% 4299

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's IMGN Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 4,522,797 shares — an estimated $134M sold.

D.E. Shaw & Co first reported a position in IMGN in Q4 2014 and held it in 31 quarters. The position peaked at $134M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • D.E. Shaw & Co reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 4,522,797 Immunogen Inc shares in Q1 2024, an estimated $134M.
  • D.E. Shaw & Co first reported a position in Immunogen Inc in Q4 2014 and held it in 31 quarters.
  • D.E. Shaw & Co's Immunogen Inc position peaked at $134M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.